Larson Financial Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.9K | Sell |
1,399
-867
| -38% | -$47.7K | ﹤0.01% | 923 |
|
|
2025
Q1 | $160K | Buy |
2,266
+1,898
| +516% | +$134K | 0.01% | 666 |
|
|
2024
Q4 | $24.2K | Buy |
368
+190
| +107% | +$12.5K | ﹤0.01% | 1142 |
|
|
2024
Q3 | $12.5K | Buy |
178
+1
| +0.6% | +$70 | ﹤0.01% | 1376 |
|
|
2024
Q2 | $14.6K | Hold |
177
| – | – | ﹤0.01% | 1148 |
|
|
2024
Q1 | $15.5K | Hold |
177
| – | – | ﹤0.01% | 943 |
|
|
2023
Q4 | $17.1K | Sell |
177
-13
| -7% | -$1.25K | ﹤0.01% | 889 |
|
|
2023
Q3 | $16.8K | Buy |
190
+13
| +7% | +$1.15K | ﹤0.01% | 864 |
|
|
2023
Q2 | $15.3K | Hold |
177
| – | – | ﹤0.01% | 812 |
|
|
2023
Q1 | $17.2K | Buy |
177
+14
| +9% | +$1.36K | ﹤0.01% | 781 |
|
|
2022
Q4 | $16.9K | Hold |
163
| – | – | ﹤0.01% | 733 |
|
|
2022
Q3 | $14K | Hold |
163
| – | – | ﹤0.01% | 701 |
|
|
2022
Q2 | $14K | Hold |
163
| – | – | ﹤0.01% | 622 |
|
|
2022
Q1 | $13K | Hold |
163
| – | – | ﹤0.01% | 590 |
|
|
2021
Q4 | $14K | Buy |
+163
| New | +$14K | ﹤0.01% | 605 |
|